Qiagen N.V.
Status: Publicly traded
Direct answer
Qiagen N.V. is publicly traded on XETRA under the ticker QIA.DE.
QIAGEN N.V. delivers comprehensive "sample to insight" solutions globally, enabling the transformation of biological materials into valuable molecular insights. Their extensive product portfolio addresses various stages of molecular analysis, starting with primary sample technologies. This includes a range of consumables such as kits for nucleic acid stabilization and purification from initial biological samples, as...
Can you invest in Qiagen N.V.?
Yes. Qiagen N.V. trades publicly on XETRA as QIA.DE.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.